When Steve Carr, senior director of the Proteomics Platform at the Broad Institute of MIT and Harvard, began working in proteomics, the field was able to detect only the most abundant proteins in a ...

Consortium includes top universities, hospitals and industry partners, led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust Akoya’s platforms will be used for deep spatial ...

A global team of researchers at the Max Planck Institute of Biochemistry has made a discovery that has helped save the lives of patients suffering from toxic epidermal necrolysis. This rare but often ...

When Matthew Padula was diagnosed with a rare bladder cancer in 2020, he knew there was a challenging road ahead of him. As a researcher at the University of Technology Sydney, his first instinct was ...

Spatial proteomics, selected as the 2024 Method of the Year by Nature Methods journal (1), is an emerging scientific discipline that focuses on studying proteins within their spatial contexts, ...

Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape™ XR, a next-generation spatial proteomics platform designed to advance the development of diagnostic and prognostic assays by ...

Spatial proteomics represents a revolutionary frontier in molecular biology, enabling researchers to explore protein expression while preserving the critical spatial context of tissue architecture.

Spatial omics is transforming how researchers understand tissue biology, revealing the complex interplay between cells in health and disease. While RNA expression studies provide important molecular ...

Protein function is inherently spatial—the same molecule can elicit distinct biological outcomes depending on its localization, interacting partners, and surrounding microenvironment. Conventional ...

The syndrome associated with coronavirus infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease 2019 (COVID-19)) is a complex medical condition first ...

The omics era is in large part defined by a shift from the old target-of-interest days to an unbiased, discovery-first mindset: from a few genes to the whole genome, from a couple of proteins to the ...

During his training in clinical dermatology, Thierry Nordmann encountered several patients with a rare, horrifying condition called toxic epidermal necrolysis, or TEN. Widely considered to be the only ...